Jean Bénard

6.4k total citations
150 papers, 4.5k citations indexed

About

Jean Bénard is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jean Bénard has authored 150 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Neurology, 67 papers in Molecular Biology and 57 papers in Oncology. Recurrent topics in Jean Bénard's work include Neuroblastoma Research and Treatments (68 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Jean Bénard is often cited by papers focused on Neuroblastoma Research and Treatments (68 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Jean Bénard collaborates with scholars based in France, United States and Switzerland. Jean Bénard's co-authors include G Riou, Sétha Douc‐Rasy, Ute M. Moll, Michael P. LaQuaglia, Jean‐Charles Ahomadegbe, Olivier Hartmann, Dominique Valteau‐Couanet, Gilda Raguénez, Pierre Duvillard and Étienne Blanc and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jean Bénard

148 papers receiving 4.4k citations

Peers

Countries citing papers authored by Jean Bénard

Since Specialization

Citations

This map shows the geographic impact of Jean Bénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Bénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Bénard more than expected).

Fields of papers citing papers by Jean Bénard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Bénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Bénard. The network helps show where Jean Bénard may publish in the future.

Co-authorship network of co-authors of Jean Bénard

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Bénard. A scholar is included among the top collaborators of Jean Bénard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Bénard. Jean Bénard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding 2015 ·European Journal of Pharmaceutical Sciences ·Cindy S. Chu, Marie‐Sophie Noël‐Hudson, Jean Bénard, Tâp Ha‐Duong, (unknown), Robert Farinotti, Laurence Bonhomme‐Faivre	2
2	Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant 2012 ·Molecular Cancer Therapeutics ·(unknown), Charles‐Henry Gattolliat, Frédéric Pendino, Josette Hillion, Éric Nguyen, Sophie Bombard, Sétha Douc‐Rasy, Jean Bénard, E. Segal	13
3	p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma 2010 ·BMC Cancer ·(unknown), Marie‐Line Puiffe, Dominique Valteau‐Couanet, Marc Lipinski, Jean Bénard, Mounira Amor-Guéret	17
4	Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis 2010 ·Journal of Clinical Investigation ·(unknown), Jorge Rubén Cabrera, Céline Delloye‐Bourgeois, Gabriel Ichim, Jean‐Guy Delcros, Marie‐Anne Raquin, Raphaël F. Rousseau, Valérie Combaret, Jean Bénard, Servane Tauszig-Delamasure, Patrick Mehlen	59
5	Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma 2009 ·BMC Cancer ·Gilda Raguénez, Annick Mühlethaler‐Mottet, Roland Meier, (unknown), Jean Bénard, Nicole Groß	13
6	MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S 2008 ·Molecular Oncology ·Jean Bénard, Gilda Raguénez, Audrey Kauffmann, Alexander Valent, Hugues Ripoche, V. Joulin, Bastien Job, Gisèle Danglot, (unknown), Thomas Robert, Marie‐José Terrier‐Lacombe, Agnès Chassevent, Serge Koscielny, Matthias Fischer, Frank Berthold, Marc Lipinski, Thomas Tursz, Philippe Dessen, Vladimir Lazar, Dominique Valteau‐Couanet	50
7	Establishment of a new human prostate cancer cell line, IGR-CaP1, from a localized epithelial prostate cancer. 2007 ·Cancer Research ·Anne Chauchereau, Sylvestre Le Moulec, G. Fromont, Catherine Gaudin, Pierre Validire, (unknown), A. Plantade, Christophe Massard, (unknown), Jean Bénard, Karim Fizazi	1
8	Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours 2006 ·Human Reproduction ·(unknown), F. Olivennes, (unknown), (unknown), Geri Méduri, Catherine Lhommé, Pierre Duvillard, Jean Bénard, Philippe Morice	25
9	Low expression of Wnt-5a gene is associated with high-risk neuroblastoma 2004 ·Oncogene ·Étienne Blanc, G. Le Roux, Jean Bénard, Gilda Raguénez	81
10	Prédire le potentiel métastatique : l’apport de la génomique 2003 ·médecine/sciences ·Gilda Raguénez, Jean Bénard	1
11	Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function 2003 ·The Journal of Immunology ·Jérôme Thiery, Guillaume Dorothée, Hédi Haddada, Hamid Echchakir, Catherine Richon, Rodica Stancou, Isabelle Vergnon, Jean Bénard, Fathia Mami‐Chouaib, Salem Chouaı̈b	26
12	Abnormal Number of X Chromosomes and Neuroblastic Tumors 2001 ·The American journal of pediatric hematology/oncology ·Daniel Satgé, Annie J. Sasco, Dominique Plantaz, Jean Bénard, Michel Vekemans	4
13	In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of Micronuclei 2001 ·American Journal Of Pathology ·Alexander Valent, Jean Bénard, Bernard Clausse, Michel Barrois, Dominique Valteau‐Couanet, Marie‐José Terrier‐Lacombe, Barbara A. Spengler, Alain Bernheim	61
14	Vers une carte génétique fonctionnelle des neuroblastomes métastatiques pour une thérapeutique adaptée 2001 ·Bulletin du Cancer ·Gilda Raguénez, (unknown), Étienne Blanc, David Goldschneider, Michel Barrois, Dominique Valteau‐Couanet, Jean Bénard	1
15	[TSG101 and breast cancer: a correctly named tumor-suppressor gene?]. 1997 ·PubMed ·Jean Bénard, J.C. Ahomadegbe	1
16	Trace metal content in distinct genotypes of human neuroblastoma cells: Preliminary results 1997 ·Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms ·Richard Ortega, Barbara Gouget, Ph. Moretto, Claire Michelet, Jean Bénard, Claire Sergeant, Y. Llabador, M. Simonoff	6
17	N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. 1997 ·Journal of Clinical Oncology ·H Rubie, Olivier Hartmann, Jean Michon, Didier Frappaz, Carole Coze, Pascal Chastagner, M.C. Baranzelli, Dominique Plantaz, Hervé Avet‐Loiseau, Jean Bénard, Olivier Delattre, M Favrot, (unknown), Antoine Thyss, Yves Pérel, Christophe Bergeron, (unknown), J.P. Vannier, J Lemerle, D. Sommelet	148
18	Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts 1996 ·British Journal of Cancer ·Gilles Vassal, (unknown), (unknown), (unknown), (unknown), Jean Bénard, Jackie Morizet, I Boland, P Ardouin, Brigitte Bressac–de Paillerets, Alain Gouyette	89
19	Somatostatin-14 Mainly Binds the Somatostatin Receptor Subtype 2 in Human Neuroblastoma Tumors 1996 ·Neuroendocrinology ·Grégoire Prévost, (unknown), Cécile Viollet, (unknown), Pierre Roubert, Jean Bénard, (unknown)	17
20	c‐crbB2 gene amplification and protein expression in ovarian epithelial tumors: Evaluation of their respective prognostic significance by multivariate analysis 1995 ·International Journal of Cancer ·Anne Fajac, Jean Bénard, Catherine Lhommé, Annie Rey, Pierre Duvillard, (unknown), Jean‐François Bernaudin, G Riou	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact